semaglutide age approval A new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% GLP-1s | AgelessRx
Description
doi: 10.1159/000080731
If you are prescribed tirzepatide, it is important to take it exactly as directed and to follow your doctors advice about specific diet and exercise practices
The high cost of GLP-1 medication is the biggest impediment, though consumer adoption has also been hindered by the lack of insurance coverage, drug shortages, and the medications physical side effects
Looking ahead, Medicares evolving approach to GLP-1 coverage is likely to reshape access and competition across the obesity treatment market
Get your homocysteine checked during blood work
Furthermore, it slows stomach emptying and increases satiety, which can assist in weight loss in those with type 2 diabetes
